Scarica l'app Stockscreener
8.89
2.52%
-0.23
Pre-mercato:
9.01
0.12
+1.35%
Precedente Chiudi:
$9.12
Aprire:
$8.99
Volume 24 ore:
11.72M
Relative Volume:
1.38
Capitalizzazione di mercato:
$39.32B
Reddito:
$14.54B
Utile/perdita netta:
$2.22B
Rapporto P/E:
18.25
EPS:
0.4871
Flusso di cassa netto:
$2.58B
1 W Prestazione:
+0.57%
1M Prestazione:
-2.41%
6M Prestazione:
-5.43%
1 anno Prestazione:
-19.69%
Intervallo 1D:
$8.88
$9.0077
Intervallo di 1 settimana:
$8.65
$9.1451
Portata 52W:
$8.65
$11.28
Haleon Plc Adr Stock (HLN) Company Profile
Compare HLN vs TAK, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HLN
Haleon Plc Adr
|
8.89 | 40.34B | 14.54B | 2.22B | 2.58B | 0.4871 |
TAK
Takeda Pharmaceutical Co Adr
|
15.74 | 49.29B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.26 | 39.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.82 | 33.30B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
544.69 | 23.34B | 3.17B | 1.29B | 1.01B | 27.09 |
Haleon Plc Adr Stock (HLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-23 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-09-16 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-09-10 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-05-27 | Aggiornamento | BNP Paribas Exane | Neutral → Outperform |
| 2025-05-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-05 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-01-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-08-06 | Iniziato | Berenberg | Buy |
| 2024-08-06 | Downgrade | Goldman | Buy → Neutral |
| 2024-06-05 | Iniziato | Berenberg | Buy |
| 2024-04-17 | Iniziato | HSBC Securities | Buy |
| 2023-12-11 | Ripresa | Jefferies | Buy |
| 2023-11-01 | Iniziato | Morgan Stanley | Overweight |
| 2023-05-24 | Iniziato | Stifel | Hold |
| 2023-04-06 | Aggiornamento | Argus | Hold → Buy |
| 2023-04-04 | Iniziato | Bernstein | Outperform |
| 2022-12-07 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-09-28 | Iniziato | Argus | Hold |
Mostra tutto
Haleon Plc Adr Borsa (HLN) Ultime notizie
Haleon Advances Pediatric Pain Relief Combo With New Phase I Study - TipRanks
Haleon Shares Rose on Friday—What’s Next for the Stock - Bez Kabli
HLN News | HALEON PLC-ADR (NYSE:HLN) - ChartMill
Haleon (HLN) Stock Price, News & Analysis $HLN - MarketBeat
Why Haleon PLC Sponsored ADR Shares Suddenly Jumped - TipRanks
TUMS Kicks Off the "TUMS Food Match Cup," a Celebration of Global Soccer Fandom and Food Love Through Bold Flavor Mashups - Sahm
HLN Stock Price, Quote & Chart | HALEON PLC-ADR (NYSE:HLN) - ChartMill
Haleon executives acquire shares through dividend reinvestment program By Investing.com - Investing.com
‘For The Assist’: Haleon Canada launches national campaign with Canada Soccer to celebrate the small health supports behind Canadian wellbeing - Sahm
Haleon director acquires shares through dividend reinvestment on London Stock Exchange By Investing.com - Investing.com
Haleon discloses dividend-driven share purchase by senior independent director - TipRanks
LCUT or HLN: Which is the better value stock right now? - MSN
Haleon plc stock (GB00BMX86B70): Consumer health giant focuses on growth amid market shifts - AD HOC NEWS
Haleon Plc (LSE:HLN) Share Price, History, & News - twelfthmagpie.com
Haleon completes purchase of 10.2 million shares for cancellation - Investing.com
Haleon publishes updated listing particulars for £10 billion EMTN program By Investing.com - Investing.com South Africa
Haleon publishes updated listing particulars for £10 billion EMTN program - Investing.com India
What Makes Galderma Group AGUnsponsored ADR (GALDY) a New Strong Buy Stock - Yahoo Finance
Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits - Sahm
Haleon reports total voting rights and share capital update - Investing.com
Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Earnings call transcript: Haleon Q1 2026 shows resilience with slight EPS beat - Investing.com Canada
Haleon plc Stock (GB00BMX86B70): Q1 Revenue Up 0.1%, Stands by 3-5% Growth Outlook - AD HOC NEWS
Haleon shareholders approve all resolutions at 2026 annual general meeting - Investing.com
Haleon shareholders approve all resolutions at 2026 AGM - Investing.com
Haleon Q1 Earnings Call Highlights - Yahoo Finance
Haleon Q1 2026 slides: oral health shines amid soft cold, flu season - Investing.com India
- Start with "Earnings call transcript:" followed by an engaging and factual title. - Investing.com
Haleon PLC Sponsored ADR (NYSE:HLN) Sees Large Drop in Short Interest - MarketBeat
Haleon Launches For the Assist Campaign in Partnership with the U.S. Soccer Federation Featuring Stars Tyler Adams and Crystal Dunn - ChartMill
Haleon names Richard Manso as US chief marketing officer - Investing.com
Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday Health - ChartMill
Haleon names Richard Manso as US chief marketing officer By Investing.com - Investing.com India
Haleon buys back 8.7 million shares for cancellation under March program - Investing.com
Massachusetts Financial Services Co. MA Takes Position in Haleon PLC Sponsored ADR $HLN - MarketBeat
What makes Haleon PLC sponsored ADR (HLN) a new buy stock - MSN
Haleon (NYSE:HLN) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Haleon’s New Sensitivity Toothpaste Trial in China: What Investors Should Watch - TipRanks
Third View Private Wealth LLC Takes $3.46 Million Position in Haleon PLC Sponsored ADR $HLN - MarketBeat
What Makes Haleon PLC Sponsored ADR (HLN) a New Buy Stock - Yahoo Finance
Haleon completes purchase of 7.7 million shares for cancellation - Investing.com
Douglas Lane & Associates LLC Cuts Position in Haleon PLC Sponsored ADR $HLN - MarketBeat
Haleon completes purchase of 5.27 million shares for cancellation - Investing.com
Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Voltaren Topical Pain Relief: Haleon's Flagship Product Driving Steady Consumer Staples Demand in No - AD HOC NEWS
SG Americas Securities LLC Has $5.27 Million Position in Haleon PLC Sponsored ADR $HLN - marketbeat.com
Haleon reports updated share capital and voting rights - Investing.com
Scharf Investments LLC Has $11.08 Million Holdings in Haleon PLC Sponsored ADR $HLN - MarketBeat
Haleon completes purchase of 8.9 million shares for cancellation - Investing.com
Haleon Plc Adr Azioni (HLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.72%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):